UPLOAD Filing
RenovoRx, Inc.
Date: April 22, 2026 · CIK: 0001574094 · Accession: 0000000000-26-004102
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295108
Letter
Re: RenovoRx, Inc. Registration Statement on Form S-3 Filed April 16, 2026 File No. 333-295108 Dear Shaun Bagai:
April 22, 2026
Shaun Bagai Chief Executive Officer RenovoRx, Inc. 2570 West El Camino Real, Suite 640 Mountain View, CA 94040
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Lawrence A. Rosenbloom, Esq.
Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
April 22, 2026
Shaun Bagai
Chief Executive Officer
RenovoRx, Inc.
2570 West El Camino Real, Suite 640
Mountain View, CA 94040
Re: RenovoRx, Inc.
Registration Statement on Form S-3
Filed April 16, 2026
File No. 333-295108
Dear Shaun Bagai:
This is to advise you that we have not reviewed and will not review your
registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Lawrence A. Rosenbloom, Esq.
</TEXT>
</DOCUMENT>